Doctors treat COPD in Pennsylvania

Chronic Obstructive Pulmonary Disease (COPD) is a debilitating lung disease that makes breathing on one’s own extremely difficult. According to an article published by the University of Pittsburgh Medical Center, the number one cause of COPD is smoking. Other factors that might lead to COPD are secondhand smoke, air pollution, and being exposed to hazardous substances like dust and chemicals. Pittsburgh sees many cases of COPD as a direct result of occupational hazards. In July of 2015, however, Lung Institute doctors treat COPD in Pennsylvania.

Unfortunately many Pittsburgh, Pennsylvania residents suffer from COPD. When diagnosed with COPD, a person might feel overwhelmed or hopeless because, unfortunately, COPD cannot be cured. Things like medications, inhalers and oxygen therapy help lessen the symptoms of COPD.  There is a relatively new cellular therapy that has been very effective for many patients. The cellular therapy is a minimally invasive procedure that harnesses the body’s own healing properties. The Lung Institute specializes in treating patients with debilitating lung disease with cellular therapy.

Stem Cell Patient Testimonial

Many patients have had great results from cellular therapy. Lung Institute patient, Gary W, talks about his experience with cellular therapy. “I took care of myself all winter. I plowed my own driveway, but I always wore a mask, I don’t suck in the cold air. But regardless, I haven’t used oxygen in months. I have a portable oxygen unit that I had been using for a while, I can’t tell you long ago it’s been. But it has definitely made a difference. I’m very impressed and I recommend it to everybody.”

 The Lung Institute is Coming to Pennsylvania

The Lung Institute has completed over 800 treatments in the past two years, and is expanding rapidly. They are looking forward to opening a new clinic in Pittsburgh in July 2015.

About the Staff

Dr. Jack Coleman, Jr., MD, will be the Medical Director of the Pittsburgh clinic. Dr. Coleman earned his medical degree from the University of Cincinnati. He later became an otolaryngology resident at the University of Pittsburgh Eye and Ear Hospital. He also served as a Lieutenant Commander and Commander in the United States Naval Reserve. Dr. Coleman is a diplomate of the National Board of Medical Examiners, is Board Certified in Otolaryngology and is a Fellow of the American Academy of Otolaryngology and Head and Neck Surgery. He is also a member of numerous medical societies including the American Medical Association, American Rhinologic Society, Association of Military Surgeons of the United States and the Pan-American Society of Otolaryngology. Along with his distinguished medical career, Dr. Coleman is a published author for several medical books and is referenced in numerous medical journals.

Although Pittsburgh has some of the highest levels of air pollution in the United States, there is hope for those suffering from COPD. The Lung Institute is on its way.

If you or a loved one suffers from chronic lung disease, contact the Lung Institute to find out if cellular therapy can help get your life back within reach. Contact us by calling (800) 729-3065 to see if you qualify.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.